SCHEMBL8136292

SCHEMBL8136292

CC(C)c1cc(C(C)C)c(CC(=O)Cl)c(C(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.50
FABP3 P05413 2/20 0.50
SOAT2 O75908 1/20 0.46
MYC P01106 1/20 0.46
SOAT1 P35610 1/20 0.46
MAP2K3 P46734 1/20 0.46
FABP5 Q01469 1/20 0.44
GABRA1 P14867 3/20 0.42
GABRB2 P47870 1/20 0.42
GAA P10253 2/20 0.33
LPAR1 Q92633 2/20 0.33
GLRA1 P23415 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GABRB1 P18505 1/20 0.32
EIF4A3 P38919 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RARG P13631 1/20 0.32
RXRA P19793 1/20 0.32
PPARG P37231 1/20 0.32
GABRG2 P18507 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21962918 0.87 FABP3 (0.38) FABP4FABP3SOAT2MYCSOAT1
SCHEMBL25831162 0.84 FABP3 (0.36) FABP4FABP3SOAT2MYCSOAT1
SCHEMBL20681156 0.83 NLRP3 (0.40) FABP4FABP3SOAT2MYCSOAT1
SCHEMBL8137246 0.82 FABP3 (0.57) FABP4FABP3SOAT2MYCSOAT1
SCHEMBL7207662 0.79 FABP4 (0.58) FABP4FABP3SOAT2MYCSOAT1
SCHEMBL21962203 0.79 GPR35 (0.35) FABP4FABP3SOAT2MYCSOAT1
SCHEMBL8132569 0.78 GABRA1 (0.55) SOAT2MYCSOAT1MAP2K3GABRA1
SCHEMBL7484474 0.78 FABP4 (0.67) FABP4FABP3SOAT2MYCSOAT1
SCHEMBL23319858 0.78 GLRA1 (0.38) SOAT2MYCSOAT1MAP2K3LPAR1
SCHEMBL22774257 0.76 FABP3 (0.39) FABP4FABP3FABP5GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6017905-A TREATMENT OF HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 2000-01-25 US disclosed
US-5807846-A TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed